Volume 37 Issue 3
May  2021
Turn off MathJax
Article Contents
LU Dong-xue, YAN Jing, SUN Zhi-guang, LI Xuan, LIU Feng, WANG Ya-jun, GE Fei. Clinical Efficacy and Mechanism of Wumei Pill in the Treatment of Chemotherapy-induced Intestinal Mucositis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(3): 371-375. doi: 10.14148/j.issn.1672-0482.2021.0371
Citation: LU Dong-xue, YAN Jing, SUN Zhi-guang, LI Xuan, LIU Feng, WANG Ya-jun, GE Fei. Clinical Efficacy and Mechanism of Wumei Pill in the Treatment of Chemotherapy-induced Intestinal Mucositis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(3): 371-375. doi: 10.14148/j.issn.1672-0482.2021.0371

Clinical Efficacy and Mechanism of Wumei Pill in the Treatment of Chemotherapy-induced Intestinal Mucositis

doi: 10.14148/j.issn.1672-0482.2021.0371
  • Received Date: 2020-11-22
    Available Online: 2021-12-21
  • Publish Date: 2021-05-10
  • OBJECTIVE   To observe the effect of Wumei pill on diarrhea in chemotherapy-induced intestinal mucositis (CIM) and its possible mechanism of action.METHODS   We selected 50 CIM outpatients with diarrhea in Hai'an TCM Hospital, and divided them into the treatment group with 25 cases and the control group with 25 cases in accordance with the random number table. In the control group, oral loperamide was administered, while as for the treatment group, Chinese herbal decoction Wumei pill was given. The total course of treatment was four weeks. The incidence rate of diarrhea and the total effective rate of the patients were observed, and the scores of traditional Chinese medicine (TCM) syndrome were evaluated. In addition, we measured serum inflammatory factors and After treatment, the incidence rate of diarrhea and the scores of TCM syndrome were decreased in both groups (P < 0.05, P < 0.01), and results in the treatment group were better than those in the control group (P < 0.01). The clinical efficacy rate of the treatment group was higher than that of the control group (P < 0.05). The levels of serum interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), diamine oxidase (DAO), endothelin (ET) and D-lactate were decreased (P < 0.05, P < 0.01), while the levels of interleukin 10 (IL10) were increased (P < 0.01). The abundances of enteropathogenic bacteria were reduced while the abundances of probiotics were increased (P < 0.05, P < 0.01), and the treatment group were better than the control group (P < 0.01).CONCLUSION   Wumei pill can significantly improve the symptoms associated with diarrhea of CIM, and the mechanism may be related to the anti-inflammatory response, improvement of intestinal mucosal barrier function and regulation of intestinal flora under the multi-target effect of the Chinese herbal compound.

     

  • loading
  • [1]
    [2]
    张翔, 杨觅, 胡静, 等. XELOX方案与FOLFOX方案术后辅助治疗结直肠癌的疗效及副反应比较[J]. 贵州医药, 2017, 41(10): 1051-1052. doi: 10.3969/j.issn.1000-744X.2017.10.016
    [3]
    中华医学会. 临床诊疗指南: 肿瘤分册[M]. 北京: 人民卫生出版社, 2009: 138.
    [4]
    胡品津, 谢灿茂. 内科疾病鉴别诊断学[M]. 6版. 北京: 人民卫生出版社, 2014: 1156-1158.
    [5]
    中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002: 5860.
    [6]
    张新峰, 乔翠霞, 程旭锋, 等. 中西医结合治疗不同中医证型化疗相关性腹泻[J]. 中成药, 2015, 37(9): 1914-1916. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA201509009.htm
    [7]
    ZHANG L, JIN YY, PENG J, et al. Qingjie Fuzheng Granule attenuates 5-fluorouracil-induced intestinal mucosal damage[J]. Biomed Pharmacother, 2019, 118: 109223. doi: 10.1016/j.biopha.2019.109223
    [8]
    ZHANG ZC, LI YX, SHEN P, et al. Administration ofgeniposide ameliorates dextran sulfate sodium-induced colitis in mice via inhibition of inflammation and mucosal damage[J]. Int Immunopharmacol, 2017, 49: 168-177. doi: 10.1016/j.intimp.2017.05.033
    [9]
    ABDO SA, WADIE W, ABDELSALAM RM, et al. Potential anti-inflammatory effect of escitalopram in iodoacetamide-induced colitis in depressed ovariectomized rats: Role of α7-nAChR[J]. Inflammation, 2019, 42(6): 2056-2064. doi: 10.1007/s10753-019-01068-0
    [10]
    CHEN HT, ZHANG F, LI RR, et al. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota[J]. Biomedecine Pharmacother, 2020, 124: 109829. doi: 10.1016/j.biopha.2020.109829
    [11]
    杜小超. 益生菌联合早期肠内营养治疗急性重症胰腺炎的临床疗效[J]. 临床合理用药杂志, 2020, 13(30): 18-20, 23. https://www.cnki.com.cn/Article/CJFDTOTAL-PLHY202030007.htm
    [12]
    陈佳, 周国珍. 乌梅丸加减方联合阿嗪米特、益生菌治疗LC术后腹泻对患者大便性状及肠黏膜屏障功能的影响[J]. 四川中医, 2020, 38(7): 117-120. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZY202007037.htm
    [13]
    LI S, QI Y, CHEN L, et al. Effects of Panax ginseng polysaccharides on the gut microbiota in mice with antibiotic-associated diarrhea[J]. Int J Biol Macromol, 2019, 124: 931-937. doi: 10.1016/j.ijbiomac.2018.11.271
    [14]
    李恒, 左建平, 唐炜. 小檗碱通过调控溃疡性结肠炎肠道神经免疫炎症保护黏膜屏障损伤[J]. 中国药理学与毒理学杂志, 2019, 33(9): 673. https://www.cnki.com.cn/Article/CJFDTOTAL-YLBS201909052.htm
    [15]
    崔引航, 谢家诚, 徐东强, 等. 乌梅丸加减治疗寒热错杂型溃疡性结肠炎的临床效果分析[J]. 临床医药文献电子杂志, 2020, 38: 12-14. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX202038008.htm
    [16]
    苏良伟, 郑欢, 黄马养, 等. 乌梅丸治疗腹泻型肠易激综合征的Meta分析[J]. 中国中医急症, 2019, 28(9): 1554-1558. doi: 10.3969/j.issn.1004-745X.2019.09.014
    [17]
    马清林, 臧凯宏, 杜丽东, 等. 乌梅丸治疗溃疡性结肠炎的网络药理学研究[J]. 中药药理与临床, 2019, 35(2): 11-16.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(7)

    Article Metrics

    Article views (392) PDF downloads(174) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return